Holen Sie sich die Stockscreener-App
4.58
0.66%
0.03
Handel nachbörslich:
4.56
-0.02
-0.44%
Schlusskurs vom Vortag:
$4.55
Offen:
$4.48
24-Stunden-Volumen:
1.35M
Relative Volume:
0.51
Marktkapitalisierung:
$150.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-87.23M
KGV:
-1.5421
EPS:
-2.97
Netto-Cashflow:
$-82.77M
1W Leistung:
-6.72%
1M Leistung:
+209.46%
6M Leistung:
+316.36%
1J Leistung:
-47.60%
1-Tages-Spanne:
$4.36
$4.7797
1-Wochen-Bereich:
$4.36
$5.20
52-Wochen-Spanne:
$0.8801
$9.1869
Pepgen Inc Stock (PEPG) Company Profile
Firmenname
Pepgen Inc
Sektor
Branche
Telefon
703-456-8000
Adresse
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Vergleichen Sie PEPG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
4.58 | 312.75M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Eingeleitet | Guggenheim | Buy |
| 2024-12-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-07-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-21 | Eingeleitet | H.C. Wainwright | Buy |
Pepgen Inc Aktie (PEPG) Neueste Nachrichten
Chart overlay techniques for tracking PepGen Inc.2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
What technical models suggest about PepGen Inc.’s comebackInflation Watch & Low Risk High Win Rate Picks - newser.com
What risks investors should watch in PepGen Inc. stockJuly 2025 Breakouts & Safe Entry Point Identification - newser.com
Real time social sentiment graph for PepGen Inc.Quarterly Profit Review & Step-by-Step Swing Trade Plans - newser.com
Can trapped investors hope for a rebound in PepGen Inc.Weekly Trade Report & AI Forecasted Entry and Exit Points - newser.com
Is PepGen Inc. stock trading near support levelsInsider Buying & Real-Time Buy Signal Notifications - newser.com
How to build a custom watchlist for PepGen Inc.Stop Loss & Technical Pattern Based Signals - newser.com
Building trade automation scripts for PepGen Inc.July 2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - ACCESS Newswire
PepGen Inc Stock Analysis and ForecastPortfolio Risk Assessment & Multiply Your Assets With Time-Tested Picks - earlytimes.in
PepGen's (PEPG) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Tick level data insight on PepGen Inc. volatilityJuly 2025 Fed Impact & Daily Market Momentum Tracking - newser.com
Will PepGen Inc. outperform the marketPortfolio Return Summary & Expert-Curated Trade Recommendations - newser.com
BofA Securities Maintains PepGen(PEPG.US) With Sell Rating, Raises Target Price to $3 - 富途牛牛
PepGen price target raised to $3 from $1 at BofA - TipRanks
Is PepGen Inc. stock poised for growthGap Up & Weekly Chart Analysis and Trade Guides - newser.com
Is PepGen Inc. stock gaining market sharePortfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
Why PepGen Inc. stock remains resilientEarnings Performance Report & Real-Time Chart Breakout Alerts - newser.com
PepGen: DMD Discontinued, Ways To Go With DM1 (NASDAQ:PEPG) - Seeking Alpha
Insiders Snap Up $54M in Biotech and Offshore Driller Stocks - 24/7 Wall St.
Can momentum traders help lift PepGen Inc.Share Buyback & AI Powered Market Entry Ideas - newser.com
Is PepGen Inc. reversing from oversold territoryGlobal Markets & Stock Timing and Entry Methods - newser.com
Is PepGen Inc. trending in predictive chart models2025 Price Action Summary & Low Risk Entry Point Tips - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
PepGen says FREEDOM clinical study achieves all key objectives - MSN
What data driven models say about PepGen Inc.’s futureWeekly Gains Report & Daily Profit Focused Screening - newser.com
Using Bollinger Bands to evaluate PepGen Inc.2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com
H.C. Wainwright Maintains PepGen(PEPG.US) With Buy Rating, Raises Target Price to $12 - 富途牛牛
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle So - PharmiWeb.com
Wedbush Issues Negative Outlook for PepGen Earnings - MarketBeat
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society - Business Wire
Major Stakeholder Makes Bold Move with PepGen Inc. Stock Purchase! - TipRanks
PepGen Highlights Progress in Therapy for DM1 - TipRanks
Science Enterprises Plc Oxford Purchases 200,000 Shares of PepGen (NASDAQ:PEPG) Stock - MarketBeat
Insider Stock Purchases: October 01, 2025 - Quiver Quantitative
PepGen Inc. Stock (PEPG) Opinions on Recent Insider Buying and Offering Closure - Quiver Quantitative
PepGen Inc. (PEPG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Finanzdaten der Pepgen Inc-Aktie (PEPG)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):